ArticleBlood2012
Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma.
Loredana Santo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
286 papers cite itlatest 60 shown
this paperpooled ittrialcites it